Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Macrolide and fluoroquinolone resistance of Mycoplasma genitalium in southern Spain, 2018-2019.

Sexually transmitted infections - 1 Feb 2021

de Salazar Adolfo, Barrientos-Durán Antonio, Espadafor Beatriz, Fuentes-López Ana, Chueca Natalia, Garcia Federico

Abstract excerpt

OBJECTIVES: In recent years, resistance in Mycoplasma genitalium (MG) to first-line (azithromycin) and second-line (moxifloxacin) treatment has been increasingly reported worldwide, however, no data regarding the south of Spain are available. METHODS: To determine resistance rates, MG-positive samples collected from June 2018 to June 2019 were analysed by sequencing the 23S rRNA and parC genes. RESULTS: A total...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Azithromycin
Share to DNA Topoisomerase IV

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Heterosexuality

Share to Homosexuality, Male

Share to Macrolides

Share to Moxifloxacin

Share to Mycoplasma genitalium

Share to RNA, Ribosomal, 23S

Source

Identifiers

PMID: 32661071
DOI: 10.1136/sextrans-2019-054386

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Macrolide and fluoroquinolone resistance of Mycoplasma genitalium in southern Spain, 2018-2019.PMID 32661071Read ↗

Azithromycin and moxifloxacin resistance determinants in Mycoplasma genitalium in Lleida, Spain.Semantic proximity Read ↗

Epidemiology and prevalence of mutations associated with resistance to macrolides and fluoroquinolones in Mycoplasma genitalium in a tertiary hospital from Madrid, Spain.Semantic proximity Read ↗

Estimation of antimicrobial resistance of Mycoplasma genitalium, Belgium, 2022.Semantic proximity Read ↗

An alarming high prevalence of resistance-associated mutations to macrolides and fluoroquinolones in Mycoplasma genitalium in Belgium: results from samples collected between 2015 and 2018.Semantic proximity Read ↗

Mycoplasma genitalium Macrolide and Fluoroquinolone Resistance: Prevalence and Risk Factors Among a 2013-2014 Cohort of Patients in Barcelona, Spain.Semantic proximity Read ↗

Mycoplasma genitalium antibiotic resistance-associated mutations in genital and extragenital samples from men-who-have-sex-with-men attending a STI clinic in Verona, Italy.Semantic proximity Read ↗

Macrolide and fluoroquinolone resistance in Mycoplasma genitalium in two Swedish counties, 2011–2015Semantic proximity Read ↗

Antibiotic Resistance and Genotypes of Mycoplasma genitalium during a Resistance-Guided Treatment Regime in a German University HospitalSemantic proximity Read ↗

Increases in the Macrolide Resistance of Mycoplasma genitalium and the Emergence of the A2058T Mutation in the 23S rRNA Gene: Clonal Spread?Semantic proximity Read ↗

Frequency and Correlates of Mycoplasma genitalium Antimicrobial Resistance Mutations and Their Association With Treatment Outcomes: Findings From a National Sentinel Surveillance Pilot in England.Semantic proximity Read ↗

Trends of Mycoplasma genitalium infections in Berlin, Germany, 2017-2023.Semantic proximity Read ↗

Prevalence of mutations associated with resistance to macrolides and fluoroquinolones in Mycoplasma genitalium: a systematic review and meta-analysis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.